Contact
Please use this form to send email to PR contact of this press release:
Akaal Pharma Initiates Phase-2 Clinical Trial of Topical AKP-11 for the Treatment of Atopic Dermatitis (Eczema)
TO:
Dale Dhanoa
Akaal Pharma Pty Ltd
+61394792584